U
Ulrich Bogdahn
Researcher at University of Regensburg
Publications - 347
Citations - 36060
Ulrich Bogdahn is an academic researcher from University of Regensburg. The author has contributed to research in topics: Neural stem cell & Neurogenesis. The author has an hindex of 67, co-authored 344 publications receiving 32279 citations. Previous affiliations of Ulrich Bogdahn include Hoffmann-La Roche & Volkswagen Foundation.
Papers
More filters
Journal ArticleDOI
Educational attainment and motor burden in advanced Parkinson's disease – The emerging role of education in motor reserve
TL;DR: An inverse correlation between years of education and lower UPDRS -III motor score is found after adjusting for important covariables, suggesting education may lead to an increased ability to compensate disturbances in basal ganglia circuits affecting not only for cognitive, but also for motor aspects of PD.
Journal ArticleDOI
Combinatory Biomarker Use of Cortical Thickness, MUNIX, and ALSFRS-R at Baseline and in Longitudinal Courses of Individual Patients With Amyotrophic Lateral Sclerosis
Anna M. Wirth,Andrei Khomenko,Dobri Baldaranov,Ines Kobor,Ohnmar Hsam,Thomas Grimm,Siw Johannesen,Tim-Henrik Bruun,Wilhelm Schulte-Mattler,Mark W. Greenlee,Ulrich Bogdahn +10 more
TL;DR: Precentral and postcentral cortical thinning detected by structural magnetic resonance imaging were combined with clinical (ALSFRS-R) and neurophysiological and clinical biomarkers in both cross-sectional and longitudinal analyses for an appropriate and detailed assessment of clinical state and course of disease of ALS.
Journal ArticleDOI
Magnetic resonance image findings of spinal intramedullary abscess caused by Candida albicans: case report.
TL;DR: The clinical, serological, and radiological features of a patient with a spinal intramedullary abscess caused by Candida albicans are presented and no neurosurgical approach was necessary.
Journal ArticleDOI
Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.
L. Kirzinger,Sandra Boy,Jörg Marienhagen,Gerhard Schuierer,Reiner Neu,Michael Ried,Hans-Stefan Hofmann,Karsten Wiebe,Philipp Ströbel,Christoph May,Julia Kleylein-Sohn,Claudia Baierlein,Ulrich Bogdahn,Alexander Marx,Berthold Schalke +14 more
TL;DR: Octreotide LAR plus prednisone is efficacious in patients with primary or recurrent unresectable thymoma with respect to tumor regression and adverse events were in line with the known safety profile of both agents.
Journal ArticleDOI
Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro
Sylvia Moeckel,Katharina Meyer,Petra Leukel,Fabian Heudorfer,Corinna Seliger,Christina Stangl,Ulrich Bogdahn,Martin Proescholdt,Alexander Brawanski,Arabel Vollmann-Zwerenz,Markus J. Riemenschneider,Anja-Katrin Bosserhoff,Rainer Spang,Peter Hau +13 more
TL;DR: Serious serum-free short-term treated in vitro cell cultures were used to predict treatment response in vitro with tyrosine kinase inhibitor Sunitinib and revealed additional predictive information in comparison to the evaluation of classical signaling analysis.